Disclosed herein are methods for predicting and detecting cancer risk using genetic markers such as somatic genomic alterations (SGA) that are associated with cancer risk. Also disclosed herein are methods for predicting and detecting a risk of esophageal adenocarcinoma (EA) based on the use of SGA that are associated with a risk of EA.